Medivir cold sore drug enters phase III study 

If you're new here, you may want to subscribe to my RSS feed. Thanks for visiting!

Medivir cold sore drug enters phase III study 
Pharmaceutical Business Review - Jul 07 5:59 PM
Swedish biotech firm Medivir has initiated a phase III study with the aim of demonstrating that early initiation of treatment with its investigational drug Lipsovir will prevent the development of labial herpes, commonly known as cold sores.Save to My Web
Technorati Tags: herpes, herpes treatment, herpes pictures

Tags: Herpes Information

Random Posts

• br’>adam.about.com/encyclopedia/003222.htm - 22k - Cached
• Female genital herpes - What Triggers Herpes Simplex Outbreaks